Main > A1. CORP. INDEX. A-Am No. 1 > 23andMe Inc C2
23andMe Inc C2's subsections
2015. 02.19. Bloom Syndrome
2017. 04.06. Neuro.>PD>Prognostics
2018. 03.06. Cancer Prognostics
2018. 10.31. PharmacoGenetics
2019. 03.10. Diabetes
2020. 01.13. Almirall
2021. 06.02. VP Investor Relations
2021. 11.09. BOD
2021. 11.30. CSO
2022. 09.19. Chief Product Officer
2023. 05.08. Reza Afkhami
2024. 05.29. Neuro.>PD
Web-Site
23andMe Inc C2's products
This section has no products